Vijay Kumar
Stock Analyst at Evercore ISI
(3.78)
# 1,975
Out of 4,517 analysts
537
Total ratings
50%
Success rate
4.1%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Maintained: Buy | $120 → $112 | $98.83 | +13.33% | 25 | Jul 6, 2026 | |
| A Agilent Technologies | Maintained: Buy | $140 → $148 | $136.10 | +8.74% | 18 | Jul 6, 2026 | |
| BAX Baxter International | Maintained: Buy | $22 → $24 | $23.35 | +2.78% | 20 | Jul 6, 2026 | |
| BDX Becton, Dickinson and Company | Maintained: Buy | $180 | $159.93 | +12.55% | 17 | Jul 6, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $80 → $65 | $44.62 | +45.67% | 27 | Jul 6, 2026 | |
| ENOV Enovis | Maintained: Buy | $36 → $32 | $28.07 | +14.00% | 14 | Jul 6, 2026 | |
| DHR Danaher | Maintained: Buy | $225 → $230 | $205.01 | +12.19% | 17 | Jul 6, 2026 | |
| EW Edwards Lifesciences | Maintained: Buy | $100 | $87.84 | +13.84% | 34 | Jul 6, 2026 | |
| ILMN Illumina | Maintained: Buy | $155 → $200 | $190.25 | +5.12% | 23 | Jul 6, 2026 | |
| ISRG Intuitive Surgical | Maintained: Hold | $480 → $430 | $402.33 | +6.88% | 44 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $106 → $105 | $83.56 | +25.66% | 22 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,425 → $1,350 | $1,335.09 | +1.12% | 17 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $108 → $125 | $111.70 | +11.91% | 20 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $355 → $350 | $331.20 | +5.68% | 27 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $575 → $570 | $543.19 | +4.94% | 22 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $350 → $410 | $378.19 | +8.41% | 15 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 → $110 | $93.75 | +17.33% | 24 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $335 → $320 | $319.60 | +0.13% | 8 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $160 → $150 | $115.35 | +30.04% | 5 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $160 → $200 | $155.00 | +29.03% | 6 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $56 → $102 | $91.23 | +11.81% | 11 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 → $11 | $11.26 | -6.75% | 18 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 → $17 | $16.81 | +1.13% | 12 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $25 | $16.48 | +51.70% | 9 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $19.20 | +56.25% | 1 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $20 | $16.42 | +21.80% | 21 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $85 → $80 | $65.70 | +21.77% | 13 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 → $35 | $26.78 | +30.69% | 17 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $350 → $320 | $362.44 | -11.71% | 2 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 | $3.96 | n/a | 9 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $160 → $150 | $99.44 | n/a | 14 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 → $2.5 | $0.9821 | n/a | 4 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $93 | $251.77 | n/a | 1 | Nov 9, 2022 |
Abbott Laboratories
Jul 6, 2026
Maintained: Buy
Price Target: $120 → $112
Current: $98.83
Upside: +13.33%
Agilent Technologies
Jul 6, 2026
Maintained: Buy
Price Target: $140 → $148
Current: $136.10
Upside: +8.74%
Baxter International
Jul 6, 2026
Maintained: Buy
Price Target: $22 → $24
Current: $23.35
Upside: +2.78%
Becton, Dickinson and Company
Jul 6, 2026
Maintained: Buy
Price Target: $180
Current: $159.93
Upside: +12.55%
Boston Scientific
Jul 6, 2026
Maintained: Buy
Price Target: $80 → $65
Current: $44.62
Upside: +45.67%
Enovis
Jul 6, 2026
Maintained: Buy
Price Target: $36 → $32
Current: $28.07
Upside: +14.00%
Danaher
Jul 6, 2026
Maintained: Buy
Price Target: $225 → $230
Current: $205.01
Upside: +12.19%
Edwards Lifesciences
Jul 6, 2026
Maintained: Buy
Price Target: $100
Current: $87.84
Upside: +13.84%
Illumina
Jul 6, 2026
Maintained: Buy
Price Target: $155 → $200
Current: $190.25
Upside: +5.12%
Intuitive Surgical
Jul 6, 2026
Maintained: Hold
Price Target: $480 → $430
Current: $402.33
Upside: +6.88%
Jul 6, 2026
Maintained: Buy
Price Target: $106 → $105
Current: $83.56
Upside: +25.66%
Jul 6, 2026
Maintained: Buy
Price Target: $1,425 → $1,350
Current: $1,335.09
Upside: +1.12%
Jul 6, 2026
Maintained: Buy
Price Target: $108 → $125
Current: $111.70
Upside: +11.91%
Jul 6, 2026
Maintained: Buy
Price Target: $355 → $350
Current: $331.20
Upside: +5.68%
Jul 6, 2026
Maintained: Buy
Price Target: $575 → $570
Current: $543.19
Upside: +4.94%
Jul 6, 2026
Maintained: Buy
Price Target: $350 → $410
Current: $378.19
Upside: +8.41%
Jul 6, 2026
Maintained: Buy
Price Target: $120 → $110
Current: $93.75
Upside: +17.33%
Jul 6, 2026
Maintained: Buy
Price Target: $335 → $320
Current: $319.60
Upside: +0.13%
Jul 6, 2026
Maintained: Buy
Price Target: $160 → $150
Current: $115.35
Upside: +30.04%
Jul 6, 2026
Maintained: Buy
Price Target: $160 → $200
Current: $155.00
Upside: +29.03%
Jul 6, 2026
Downgraded: Hold
Price Target: $56 → $102
Current: $91.23
Upside: +11.81%
Jul 6, 2026
Maintained: Hold
Price Target: $8 → $11
Current: $11.26
Upside: -6.75%
Jul 6, 2026
Maintained: Hold
Price Target: $16 → $17
Current: $16.81
Upside: +1.13%
Jul 6, 2026
Maintained: Buy
Price Target: $30 → $25
Current: $16.48
Upside: +51.70%
Jun 24, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $19.20
Upside: +56.25%
May 1, 2026
Maintained: Buy
Price Target: $16 → $20
Current: $16.42
Upside: +21.80%
Apr 30, 2026
Maintained: Buy
Price Target: $85 → $80
Current: $65.70
Upside: +21.77%
Apr 6, 2026
Rated: Buy
Price Target: $45 → $35
Current: $26.78
Upside: +30.69%
Feb 3, 2026
Reiterated: Buy
Price Target: $350 → $320
Current: $362.44
Upside: -11.71%
May 19, 2025
Maintained: Hold
Price Target: $3
Current: $3.96
Upside: n/a
Nov 12, 2024
Maintained: Buy
Price Target: $160 → $150
Current: $99.44
Upside: n/a
May 12, 2023
Maintained: Buy
Price Target: $2 → $2.5
Current: $0.9821
Upside: n/a
Nov 9, 2022
Maintained: Buy
Price Target: $93
Current: $251.77
Upside: n/a